MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 364 filers reported holding MEDIVATION INC in Q1 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $23,468,000 | +32.3% | 389,148 | +0.7% | 0.01% | +27.3% |
| Q1 2016 | $17,732,000 | -2.1% | 386,280 | +3.1% | 0.01% | 0.0% |
| Q4 2015 | $18,107,000 | +17.0% | 374,599 | +2.8% | 0.01% | +10.0% |
| Q3 2015 | $15,471,000 | -21.1% | 364,248 | +112.1% | 0.01% | -16.7% |
| Q2 2015 | $19,604,000 | +8.6% | 171,715 | +22.8% | 0.01% | +9.1% |
| Q1 2015 | $18,055,000 | +89.3% | 139,849 | +46.0% | 0.01% | +83.3% |
| Q4 2014 | $9,539,000 | +45.2% | 95,772 | +44.2% | 0.01% | +20.0% |
| Q3 2014 | $6,569,000 | -25.2% | 66,419 | -41.7% | 0.01% | -16.7% |
| Q2 2014 | $8,782,000 | +18.8% | 113,914 | -0.8% | 0.01% | 0.0% |
| Q1 2014 | $7,390,000 | +1.9% | 114,835 | +1.1% | 0.01% | 0.0% |
| Q4 2013 | $7,251,000 | +6.4% | 113,626 | -0.1% | 0.01% | 0.0% |
| Q3 2013 | $6,814,000 | +10.5% | 113,698 | -9.3% | 0.01% | 0.0% |
| Q2 2013 | $6,168,000 | – | 125,374 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |